We have several exciting updates to share with you, most notably the Shulgin Foundation 2025 Annual Report, which showcases the programs, partnerships, and community that carried this work forward over the past year. We are also preparing to welcome the community to Shulgin Farm for a two-day Grof® Breathwork workshop, and reflecting on recent news that the FDA has granted Breakthrough Therapy designation to a prodrug of the Shulgin compound 4-OH-DiPT.
Highlights:
- The Shulgin Foundation 2025 Annual Report
- Legacy, Lineage, and the Future of Psychedelic Communities | Three Questions with Maria Mangini, PhD, FNP
- 4/18 & 4/19: Grof® Breathwork at Shulgin Farm
- 3/15: Ketamine: The Promise & The Peril Panel
- 3/21: Spring Equinox Gathering: Cacao, Breath, & Sound Ceremony
- 4/21, 5/19, 6/23: 3-Part Series: Ceremonial Synthetics with Zach Leary
- 5/9: Creative Tools for Psychedelic Practitioners: An Art-Based Workshop 3 CECs
- Better Living Through Chemistry Now on Vimeo
- Industry News Update: FDA Grants Reunion Neuroscience Breakthrough Therapy Designation for Prodrug of Shulgin Compound 4-OH-DiPT for PPD
–